Australia's Invion jumps most in 3 yrs as skin cancer treatment trial begins

Invion

03/12/2024 24:41

** Shares of Invion  IVX.AX  rise as much as 130.6% to
A$0.415, posting their biggest intraday percentage gain since
Oct. 28, 2021
    ** Stock hits its highest level since July 16
    ** Cancer treatment developer says the first patient has
been dosed in the early-stage trial of its light absorbing
material "INV043", aimed to treat non-melanoma skin cancer
    ** About 483,000 shares change hands, compared with the
30-day average volume of around 37,000
    ** Stock trims YTD losses to 30%, including session's move



 (Reporting by Aaditya Govind Rao in Bengaluru)
 ((Aaditya.govindrao@thomsonreuters.com))